The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Ultraproct 0.92mg/g + 0.95mg/g + 5mg/g Rectal Ointment

0.92mg/g +0.95mg/g + 5mg/g milligram(s)/gram Rectal ointment

Bayer LimitedPA1410/074/001

Main Information

Trade NameUltraproct 0.92mg/g + 0.95mg/g + 5mg/g Rectal Ointment
Active SubstancesFLUOCORTOLONE PIVALATE
Fluocortolone caproate
Cinchocaine hydrochloride
Strength0.92mg/g +0.95mg/g + 5mg/g milligram(s)/gram
Dosage FormRectal ointment
Licence HolderBayer Limited
Licence NumberPA1410/074/001

Group Information

ATC CodeC05AA Corticosteroids
C05AA08 fluocortolone

Status

Authorised/WithdrawnAuthorised
Licence Issued01/04/1978
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusMarketed

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back